ARCHIVES

FDA To Reorganize Oncology Office Into Four Divisions By Disease Type

This article is from The Cancer Letter archive.

Vol. 36 No. 30 | August 6, 2010

Download PDF Visit The Full Archive

Related Articles

Final Issue Of 1992

December 11, 1992

IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC

March 28, 2014

Senators Call Mammography Debate Confusing, Say Screening “Saves Lives”.

March 8, 2002

In Brief: DeVita On Laetrile Hit List; Hammer Removal As Panel Head Sought By Love Canal Activist

November 6, 1981

Commerce Dept. Socks NCI For Cancergram Paid Subscriptions; NCAB Committee Oks OD Requests

October 22, 1982

A Provision Of The EARLY Bill Is Inserted Into House Appropriations For Labor, HHS

July 24, 2009